Evidence map›Paper›PMID 40837677›Full record

ArticleFrontiers in pediatrics2025

Early symptoms and 12-week follow-up of pediatric omicron infections during the Beijing outbreak.

Qin Hui, Jing Liu, Hua Fan, Xiaonan Hou, Xuan Li, Wei Li, Qi Zhang

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qin Hui *Department of Pediatrics, China-Japan Friendship Hospital, Beijing, China.
Jing Liu *Department of Pediatrics, China-Japan Friendship Hospital, Beijing, China.
Hua FanDepartment of Pediatrics, China-Japan Friendship Hospital, Beijing, China.
Xiaonan HouDepartment of Pediatrics, China-Japan Friendship Hospital, Beijing, China.
Xuan LiDepartment of Pediatrics, China-Japan Friendship Hospital, Beijing, China.
Wei LiDepartment of Pediatrics, China-Japan Friendship Hospital, Beijing, China.
Qi ZhangDepartment of Pediatrics, China-Japan Friendship Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To investigate the epidemiological and clinical characteristics of children infected with the Omicron variant of SARS-CoV-2 during the early outbreak in Beijing, with particular attention to symptom profiles, clinical management, and persistent symptoms at 12 weeks post-infection. Methods: This prospective study enrolled children under 18 years of age with confirmed or suspected Omicron infection in Beijing between December 2022 and January 2023. Data were collected via an online questionnaire targeting both community-managed and outpatient children. A follow-up survey was conducted at 12 weeks post-infection to assess long-term symptoms. Results: A total of 1,610 children aged 15 days to 18 years were included (median age: 3.00 years; 51.4% boys). Fever (96.4%) was the most common symptom, with a mean peak temperature of 39°C (range: 37.6-41°C). Other frequent symptoms included cough (59.1%), runny nose (43.7%), and fatigue (22.1%). The mean duration of fever was 2.05 ± 1.09 days, and the mean duration of all symptoms was 5.89 ± 4.35 days, with both showing significant differences across age groups ( Conclusions: Omicron infection affected children across all age groups, with a higher prevalence in younger children. Fever and cough were the predominant acute symptoms, while a small subset reported mild persistent symptoms 12 weeks post-infection.

Indexed as

BeijingchildrenCOVID-19omicronsymptom

Identifiers

PMID40837677
PMCPMC12361124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.